Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders
Published
NEW YORK & GENEVA--(BUSINESS WIRE)--Neurosterix launches with $63M to rapidly advance a pipeline of allosteric modulator small molecules for patients with neurological disorders.
Full Article